Researchers at Rensselaer Polytechnic Institute have made a nanoscale coating for surgical equipment, hospital walls, and other surfaces, which removes methicillin resistant Staphylococcus aureus (MRSA).
The coating is built on an enzyme found in nature.
MRSA - The Super Bug
MRSA infection is the most dreaded hospital or community acquired infection that can become life-threatening.
Advertisement
"Here we have a system where the surface contains an enzyme that is safe to handle, doesn't appear to lead to resistance, doesn't leach into the environment, and doesn't clog up with cell debris. The MRSA bacteria come in contact with the surface, and they're killed," said Jonathan S. Dordick.
In tests, 100 percent of MRSA in solution were killed within 20 minutes of contact with a surface painted with latex paint laced with the coating.
![Scientists Create New Family of]( "Scientists Create New Family of")
Scientists have developed a family of 'super-antibiotics' which can effectively treat MRSA and other deadly infections.
Unlike other antimicrobial coatings, it is toxic only to MRSA, does not rely on antibiotics, and does not leach chemicals into the environment or become clogged over time.
It can be washed repeatedly without losing effectiveness and has a dry storage shelf life of up to six months.
"We asked ourselves - were there examples in nature where enzymes can be exploited that have activity against bacteria?" Dordick said.
The answer was yes and the team quickly focused on lysostaphin, an enzyme secreted by non-pathogenic Staph strains, harmless to humans and other organisms, capable of killing Staphylococcus aureus, including MRSA, and commercially available.
"Lysostaphin has evolved over hundreds of millions of years to be very difficult for Staphylococcus aureus to resist," Ravi Kane said.
"It's an interesting mechanism that these enzymes use that we take advantage of," he added.
The research has been published in the July edition of the journal ACS Nano.
Source: ANI
Scientists Create New Family of 'Super-antibiotics' That can Effectively Treat MRSA
Scientists have developed a family of 'super-antibiotics' which can effectively treat MRSA and other deadly infections.
Advertisement
Unlike other antimicrobial coatings, it is toxic only to MRSA, does not rely on antibiotics, and does not leach chemicals into the environment or become clogged over time.
It can be washed repeatedly without losing effectiveness and has a dry storage shelf life of up to six months.
"We asked ourselves - were there examples in nature where enzymes can be exploited that have activity against bacteria?" Dordick said.
The answer was yes and the team quickly focused on lysostaphin, an enzyme secreted by non-pathogenic Staph strains, harmless to humans and other organisms, capable of killing Staphylococcus aureus, including MRSA, and commercially available.
"Lysostaphin has evolved over hundreds of millions of years to be very difficult for Staphylococcus aureus to resist," Ravi Kane said.
"It's an interesting mechanism that these enzymes use that we take advantage of," he added.
The research has been published in the July edition of the journal ACS Nano.
Source: ANI
Bees - A Potential Help Against MRSA Bugs
Bees could be the vital contributor to new treatments that are critical in fighting the virulent MRSA bug, states a new research at the University of Strathclyde.
Advertisement
 Subcontinent 'Superbug' Resistant to All Known Antibiotics Has Found Its Way to UK HospitalsExperts have warned that a new superbug that is resistant to even the most powerful antibiotics, has entered UK hospitals. | Advertisement
|
Advertisement
Recommended Reading
Latest Research News
Brain plasticity following blindness leads to superior ability in sensing signals from the heart, which has implications for bodily awareness and emotional processing.
A group of scientists were awarded £1.3 million to create a new “point of care testing” kit that detects Alzheimer's disease biomarkers.
Is there a connection between Osteoporosis and dementia? Yes, loss in bone density may be linked to an increased risk of dementia in older age.
Link between chromosome length and biological aging marker discovered. The finding helps explain why people with longer telomeres have a lower dementia risk.
Integrated structural biology helps discover how the cystic fibrosis transmembrane conductance regulator (CFTR) works.